Study Details
Testing the Study Drug Lorundrostat for Adults with Hypertension
(IRB#: IRB_00168927)
Hypertension is high blood pressure increasing the risk of serious issues such as heart failure or stroke. This study will test a drug called Lorundrostat for people with this condition. The study wants to see if the study drug will help people and is safe. People in this study will be randomly chosen to be treated with Lorundrostat or a placebo. The placebo looks like the study drug but does not have the treatment. People in the study will take Lorundrostat in addition to continuing the high blood pressure medication from a previous study. Being in the study requires attending in-person visits at the study clinic. Participation lasts about 12-13 months. Medical tests will be done to track the health of participants.
- All genders
- Over 18 years old
- Healthy Volunteers
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Healthy Volunteers
Location: In Person
Inclusion Criteria
- Ages 18 years and older
- Participation in a Lorundrostat study with the option of transitioning to the study
- Childbearing participants must agree to use specific birth control
- Able to attend in person at the study clinic
Exclusion Criteria
- Pregnant or breastfeeding
- A condition that prevents full participation
Will I be paid for my time?
Yes
IRB#: IRB_00168927
PI: Josephine Abraham
Department: NEPHROLOGY ADMINISTRATION
Approval Date: 2024-08-07 06:00:00
Specialties: Nephrology & Hypertension
I am Interested